X-linked retinitis pigmentosa (XLRP), which commonly results from mutations in the RPGR gene or the RP2 gene, is frequently more severe than other forms of retinitis pigmentosa. The onset of legal blindness occurs decades earlier in male patients than in...
Free CE/CME
Congenital adrenal hyperplasia (CAH) is a group of rare autosomal recessive disorders that arise from genetic mutation affecting enzymes involved in cortisol synthesis. Depending on the severity of mutations and the loss of functionality of 21-hydroxylase, CAH can take 2...
Vascular endothelial growth factor (VEGF) is essential in the pathogenesis of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME). As such, VEGF inhibitors have become commonly used and effective pharmacologic strategies for both diseases. However, limitations exist, such...
Free CE/CME
In this program, a panel of retina specialists share their insights into the use of newer anti-VEGF agents, which offer the opportunity for extended treatment intervals for the treatment of retinal vein occlusion (RVO), neovascular age-related macular degeneration, and diabetic...
Free CE/CME
Psoriasis (PsO) is a chronic, systemic inflammatory disease that affects 3% of US adults; it has been increasingly prevalent over the past years. The disorder is often characterized by chronicity, high grade of disability, and related comorbidities. Notably, biologic agents...
Despite the availability of multiple FDA-approved therapies for the management of patients with obesity, there are still many unmet needs in its management. As a result, additional agents are under investigation for the management of obesity. This program will review...
Free CE/CME
Recent findings indicate that hypercortisolism can be an underlying contributor to difficult-to-control type 2 diabetes (T2D), and it may occur with lower cortisol levels than noted in overt Cushing syndrome. In this program, expert faculty discuss new perspectives on the...
Schizophrenia represents a major psychiatric disorder characterized by symptoms that frequently compromise daily functioning and diminish overall quality of life. While effective management can lead to improved patient outcomes, many individuals continue to struggle with persistent or residual symptoms, medication...
This educational activity is an archive of the live presentation held on February 12, 2026. For more information about this educational activity, the faculty, and disclosures, please click here. Target Audience This educational activity is directed toward rheumatologists, nurse practitioners,...
Free CE/CME
This online, on-demand virtual symposium brings together renowned experts in treating major depressive disorder (MDD). In this educational program, these experts discuss managing patients with MDD by reviewing patient scenarios, reflecting on how to handle challenging cases, and integrating relevant...